- Drug Pipelines
- November 2024
- 60 Pages
Global
From €1422EUR$1,500USD£1,188GBP
- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- May 2024
- 137 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- January 2022
- 60 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Report
- August 2022
- 110 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- November 2022
- 36 Pages
Global
From €1896EUR$2,000USD£1,584GBP
Graves Disease Drug is a type of drug used to treat Graves Disease, an autoimmune disorder that affects the thyroid. These drugs are typically used to reduce the production of thyroid hormones, which can help reduce the symptoms of Graves Disease. Commonly used drugs include antithyroid medications, such as methimazole and propylthiouracil, as well as beta-blockers, such as propranolol. In some cases, radioactive iodine may be used to reduce the size of the thyroid gland.
Graves Disease Drug is part of the larger Immune Disorders Drugs market, which includes drugs used to treat a variety of autoimmune disorders. These drugs are used to reduce inflammation, suppress the immune system, and reduce the production of antibodies.
Some companies in the Graves Disease Drug market include AbbVie, GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more